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Objective: To compare the effectiveness and side effect of two different dosage regimes of oral  Nifedipine in the treatment 
of preterm labour 
Methods:  A double blinded randomized controlled trial in which 86 pregnant women with preterm labour were randomized 
to receive either the low or high dose regimen of Nifedipine for tocolysis. Low dose of  10 mg of oral Nifedipine then 5mg 
every 15min for 1hr  10mg 6hly for 48hrs, while the high dose was 20 mg of  oral Nifedipine  followed by 10 mg every 15 
minutes for 1hr then 20mg 6hourly for 48 hours. The primary outcome was defined by mean uterine quiescence time and 
fetomaternal side effect were compared between the groups. 
Results: The mean uterine quiescence time for the low dose and high dose regime were comparable 13.60±11.69 hours 
versus 12.16±8.90 hours (P = 0.747) respectively, there was no statistical significance difference. None of the patients in 
both groups needed rescue treatment. Forty patients (93%) versus 41 patients (95%) (P = 0.506) of  low and high dose 
respectively where able to achieve uterine quiescence within 48hours, there was no statistical significant difference. Maternal 
headache  was  higher in the high dose  compared to the low dose but not statistically significant {19% vs 5% (p = 0.08)}  
None of the women in both groups had fetal heart rate abnormality. 
Discussion: The high dose regimen of oral Nifedipine for tocolysis does not have any advantage over the low dose regime 
in terms of effectiveness for tocolysis and infact low dose had a lower maternal side effect.
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Background 
Preterm birth is one of the most important cause of perinatal 
morbidity and mortality worldwide. The effective treatment 
of preterm labor is important, not as an end in itself, but as a 
means of reducing adverse events of preterm birth. Calcium 
channel blockers have the ability to inhibit contractility in 
smooth muscle cells. Consequently, nifedipine has emerged 
as an effective and rather safe tocolytic agent for the 
management of preterm labor, several studies have shown 
that the use of nifedipine in comparison with other tocolytics 
is associated with a more frequent successful prolongation 
of pregnancy,[1] resulting in significantly fewer admissions of 
newborns to the neonatal intensive care unit (NICU),[1] and 
is associated with a lower incidence of respiratorydistress 
syndrome.[1] Also nifedipine is readily available, easy to 
use and very cheap compared with other tocolytic drugs, 
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thereby making it a very good choice in low resort settings 
like Nigeria.
The unequivocal impact of tocolysis in short-term postponement 
of delivery allowing for in-utero transfer and also allow forsteroid 
administration before delivery has prompted many investigators 
to recommend focusing future trials on determining the optimal 
dosage regime for Nifedipine in managing preterm labor.[1,2] Also 
studies comparing two different dose regimens of nifedipine 
published in the literature are very scarce compared with 
studies done to compare nifedipine to other tocolytic drugs 
or placebo.[1] Also nifedipine is readily available and cheap 
making it to be a favored choice in low resource setting like 
Nigeria and indeed Africa. An understanding of the effective 
optimal dosage and adverse reaction associated with different 
dosage regimes will help to determine dosage protocol in the 
management of preterm labor.
The investigators’ study would try to assess the safety profile 
of two different dosage regimens on the mother and the fetus 
by assessing a selected number of outcome variables. The 
data generated would be used to advocate for a change in 
the dosage protocol in managing patients presenting with 
preterm labor and would fill the existing gap in knowledge 
regarding the most effective and safest dose regimen of 
nifedipine for preterm labor.
Method
This study was carried out at the Department of Obstetrics 
and Gynaecology, Obafemi Awolowo University Teaching 
Hospitals Complex (OAUTHC) Ile-Ife, Osun State, Nigeria. It 
is a double blinded randomized controlled trial.
The drug used in this study was oral Nifedipine and it comes 
in 10 mg and 20 mg tablet forms. Two groups investigated 
comprises of low dose regime receiving 10 mg of oral 
nifedipine stat then 5 mg every 15 min for first hour followed 
by 10 mg 6 hourly for 48 h and high dose regime of 20 mg 
of oral nifedipine stat followed by 10 mg every 15 min in 
the first hour then maintenance dose was be 20 mg 6 hourly 
for 48 hours.
Inclusion criteria
All pregnant women with singleton fetus with preterm labor 
diagnosed by one uterine contraction in 10 min with intact 
membrane 3 between 28 and 34 weeks of gestation.
Exclusion criteria
The following pregnant women were excluded: Multiple 
pregnancy, Prelabour rupture of membranes, Congenital 
fetal malformations, intra uterine growth restriction (IUGR), 
previous tocolysis in this pregnancy, chorioamnionitis, 
cervical dilation >4 cm, maternal medical conditions, such 
as renal insufficiency, hepatic insufficiency, or myasthenia 
gravis. Non-reassuring fetal heart rate, maternal hypotension, 
defined as a blood pressure <90/50 mmHg, intrauterine fetal 
death, and those women who have previous allergic reaction 
to Nifedipine.
A total of 86 patients were recruited with each arm of 
the study having 43 patients. The subjects were pregnant 
women at gestational age of 28–34 weeks presenting at the 
antenatal ward with preterm labor diagnosed by one uterine 
contraction in 10 min with intact membrane.[3]Sampling 
technique was done by randomization achieved through 
sequentially numbered opaque envelopes, the contents were 
varied according to a computer generated randomization 
sequence prepared by an independent statistician, the 
numbers generated were written on two groups of envelops 
and one group handed over to the hospital pharmacy, who 
packaged the drugs and the second group handed to the 
participating doctors at the admission room. As patients 
present at the admission room they were informed about the 
research work and consent taken from them, each voluntary 
participant was asked to pick an envelope and this envelop 
waspresented to the pharmacy unit who in turn gave the 
patient a pre-packed drug inside a labeleddrug envelop 
that correspond to the number on the envelop that the 
patient presented with. At the end of the study one group 
of patient had received 10 mg of oral nifedipine stat then 
5 mg (obtained by dividing the 10 mg tablet into two equal 
halfs) every 15 min for first hour followed by 10mg 6 hourly 
for 48 h.[4] While the other group had received 20 mg of oral 
nifedipine stat followed by 10 mg (obtained by dividing the 
20mg into two equal halfs) every 15 min in the first hour then 
maintenance dose was be 20mg 6 hourly for 48 h.[5]
The following where measured as part of the proforma as 
attached in appendix A. Cervical effacement and dilatation 
were measured by performing a vaginal examination at the 
admission room and the effacement done by measuring the 
length of the cervix palpable using the assessing middle 
finger in the vagina and scored as 3 cm, 2 cm, 1 cm while 
the cervical dilatation was scored measuring the distance 
between the examining fingers (middle and index fingers) 
when placed inside the cervix and it was scored as closed, 
1 cm, 2 cm, 3 cm, 4 cm. Cardiotocography machine was 
used to determine the time to achieve uterine quicescence. 
Maternal blood pressure was taken before each dose of 
nifedipine was administered. Also the fetal heart rate was 
recorded from the cardiotocography machine before each 
dose of nifedipine was given to the patient. Maternal side 
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effect was obtained by asking if there is any from the patient 
before each dose of nifedipine was given. Statistical analysis: 
the effect of the drug and patient’s sociodemographic 
characteristics were imputed into a proforma and this was 
processed into data form. The fetal heart rate was processed 
into normal value 120–160 b/m, tachycardial >160 b/m 
andbradycardia <120 b/m during data entry and statistical 
package for the social sciences (SPSS) version 17 was used 
for analysis and result tested for significance using t-test for 
continuous variable and Chi-square for categorical variable. 
Level of confidence was set at 95% and level of significance 
was set at 0.05.
Results
A total of 86 consecutive pregnant women with preterm 
labor who met the inclusion criteria for this study were 
recruited out of 1261 admissions over the recruitment period 
hencepreterm labor accounted for 6.8% of admissions over 
the study period. Of the 86 participantonly 81 women (40 
women in LD group and 41 women in HD group) completed 
the study while 5 women (3women in LD group and 2women 
in HD group) progressed in labor to delivery.
Table 1 shows the comparison of baseline characteristics 
between the two groups. The mean age of the subjects 
in the low dose group and the high dose group were 
29.23 ± 3.9 years vs 28.86 ± 3.6 years P > 0.05, there was 
no significant difference in the mean age in both groups. 
The mean estimated gestational age at recruitment in the 
low dose group and high dose were 31.72 ± 1.9 weeks 
vs 31.05 ± 2.4 weeks P > 0.05 respectively, there was no 
significant statistical difference in the mean gestational age at 
recruitment. The cervical dilatation, the cervical length, and 
the frequency of contraction at admission had same median 
value when compared.
Table 2 shows the comparison of the low and high dose 
nifedipine regimen with respect to uterine quiescence and 
need for rescue treatment. The mean uterine quiescence time 
were 13.60 ± 11.69hrsvs12.16 ± 8.90 h P > 0.05 in the low 
and high dose regimen respectively, there was no significant 
difference when the two groups were compared.
The women who remained undelivered at 48 h were the 
patients that achieved uterine quiescence within 48 h were 
41 patients (95%) vs 40 patients (93%) P > 0.05in high vs 
low dose regimen, respectively, there was no statistical 
significance difference on comparing the two groups. 
However, 5 patients progressed to delivery during the study 
out of which 3 patients (7%) vs 2 patients (5%) P > 0.05 among 
low vs high dose groups, respectively, this shows that there 
was no significant difference in the number of women that 
progressed to delivery between the two groups. None of the 
patient needed rescue treatment.
Table 3 shows comparison of fetomaternal side effects 
between the low and high nifedipine dose regimen. All (100%) 
the patients in both groups had a normal fetal heart rate 
changes at the end of the study. However the only maternal 
side effect recorded in this study was headache in which 
2 patients (5%) vs 8 patients (19%), P > 0.05 on correction 
using fisher exact, in low and high dose respectively, this 
shows that there was no significant statistical difference in 
the maternal side effect experienced by the women.
Table 4 shows the odd ratio and 95% confidence interval for 
outcome predictors of uterine quiescence at 48 h (OR 1.66, 
Table 1: Comparison of baseline characteristics between the 
low and high Nifedipine dose regime
Low dose n=43 High dose n=43 p


























































Table 2: Comparison of the low and high dose Nifedipine 







Time to achieve uterine quiescence
(mean±SD hours) 13.60±11.69 12.16±8.90 0.747










Need for rescue treatment
Freq (%) 0 (0%) 0 (0%)
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95%CI 0.24 to 11.68) and at 12 h (OR 1.52, 95% CI 0.51to 4.52) 
which shows that there was no advantage of the high dose 
regimen over the low dose regimen. Also the maternal side 
effect (OR 2.14, 95%CI 0.95 to 4.81) showed that there was 
nodifference in both arms of the treatment.
Discussion
The dosage regimen of oral nifedipine had been varied 
from one researcher to another, there was no particular 
regimen used and there appears to be no consensus on 
the ideal regimen. The present study compared two of the 
previously tested regimens of nifedipine in the treatment of 
preterm labor, therefore the two regimes were compared 
with respect to their efficacy and side effects. The high dose 
was recommended by Bracerol et al.[5] and the low dose was 
recommended by Papatsonis et al.[4]
The present study found no statistically significant difference 
between the two regimes with respect to efficacy and side 
effect.
Nifedipine has been used and strongly recommended to 
inhibit uterine contraction for over 30 years and used as 
effective tocolytic to delay delivery for at least 48 h to allow 
corticosteroid administration to take effect or to allow for 
transfer of patient to tertiary care center with neonatal 
intensive care facility.[6]
The mean ages of women in this study in the low dose was 
29.23 ± 3.9 years and high dosewas 28.86 ± 3.6 years 
which is comparable to the study of Ghazi A et al.[7] Also in 
this study most of the patients were of low parity which is 
contradictoryto the results found in the study of copper L 
et al.,[8] where the incidence of preterm labor was high in high 
parity women. This maybe due to the fact that all the patients 
in this study were low parity or may be due to the fact that 
more of the high parity women deliver at home and did not 
come to the hospital. In the study the mean gestational age of 
31 weeks at admissionwere similar in both groups, this means 
there was no bias with respect to the application of the drug 
regimen in both groups with respect to the gestational age.
This is also comparable to the study by Weerakul W et al.[9] 
where the mean gestation age was 31.7 weeks.
This study showed that the high dose regimen had a shorter 
mean time to achieve uterine quescience than the low 
dose group, interestingly the difference was found not to 
be statistically significant when compared with each other. 
Also there was no statistical difference in the number of 
women achieving uterine quiescence at 48 h when both 
groups were compared. This is comparable to what was 
obtained by Anwar et al.[10] in a study comparing two dose 
regimes of nifedipine for the management of preterm labor 
where the result showed that there was no significant 
difference in the number of women attaining uterine 
quiescence at 48 h between the high and the low dose of 
nifedipine used in that study, with the high dose group 
having shorter mean time to achieving uterine quiescent.
Also in this study none of the patient had a rescue treatment, 
the 3 patients (7%) noted in the low dose regimen with the 
2 patients (5%) noted in the high dose group who did not 
complete the treatment with nifedipine actually progressed to 
active phase of labor and subsequently delivered within 6–8 h 
of admission. However comparing the two groups with regards 
to failure of treatment, there was no advantage conferredon 
the high dose regimen as against the low dose. This result is 
comparable to the study by Chawan paiboon et al.[11] in which 
there was failure of tocolysis in 2% of the study group.
Concerns about the fetal heart rate abnormality due to the 
effect of nifedipine on both fetal and placental circulation 
is yet to be confirmed in human study,[12]this was further 
confirmed in this study as none of the women in both groups 
had fetal tachycardia or bradycardia during the course of the 
treatment. All had a normal fetal heart rate pattern. Also this 
result is comparable with the study done by Tsatsaris et al.,[12]
which observed that there was no fetal heart rate abnormality 
noticed in all the patients studied.
Table 3: Comparison of fetomaternal side effect between the 
low and high dose regime of Nifedipine
Low dose (n-43) 
Frq(%)











































Table 4: Odds ratio and confidence interval of both low and 
high dosage regime outcome
Outcome Df OR 95%Cl
LOWER UPPER
Uter. quicent at 48 h 1 1.66 0.24 11.68
Side effect 1 2.14 0.95 4.81
Uter. Quicent at 12 h 1 1.52 0.51 4.52
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Also there were concerns about the maternal side effect, 
nifedipine been an antihypertensive with vasodilation effect 
which may predispose to hypotension and other effects, 
interestingly none of the patients had hypotension in the 
two groups, this is not comparable withthe study by Tsatsaris 
et al.[12] in which hypotension was second to headache in terms 
of maternal side effect, however a total of 679 patients were 
studied, the result of the side effect obtained inthis study 
could be possibly due to small sample size. However in the 
study by Chawanpaiboon et al.[11] complications of nifedipine 
were not detected at all in the nifedipine study group.
The only maternal side effect recorded in this study was 
headache. Headache was found to be more among women that 
were in the high dose group which was not significant, however 
the headache was not that severe to require discontinuation 
oftreatment in view of the fact that all the patients with 
headache tolerated the treatment well. This is comparableto 
the side effects notedby Anwar et al.[10] in which headache was 
the commonest side effect noted among the two groups of 
women that took two different regimen of nifedipine.
The result of this study showed that high dose of oral 
nifedipine does not seem to have an advantage over the low 
dose of oral nifedipine in terms of the mean time to achieve 
uterine quiescence and the number of women undelivered 
at 48 h. However, more women in the high dose regime 
had headache though this was not significant. None of 
the patient had abnormal fetal heart rate changes. Further 
research work with larger sample size and a much lower 
dose than the low dose used in this study could be explored.
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